mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-08 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-08 |